EUVIMEDEUVIMED entdecken
Crossref

Sustained‐Release Hydrogen‐Powered Bilateral Microneedles Integrating CD‐MOFs for In Situ Treating Allergic Rhinitis

Hang Ruan, Meng Long, Jiaqi Li, Di Zhang, Nianping Feng, Yongtai Zhang iD

Advanced Healthcare Materials · 2024-09 · 13 (22)

DOI: 10.1002/adhm.202400637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 22.05.2024. Verfasst von Hang Ruan und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of pharmacy, Shanghai University of Traditional Chinese Medicine, No.1200 Cailun Road, Pudong New Area, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Dexamethasone, Rhinitis, Allergic, Hydrogen. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoids are widely used for treating allergic rhinitis, but conventional intranasal administration encounters unfavorable nasal cilia clearance and nasal mucosal barrier. Herein, a bilateral microneedle patch is fabricated for delivering cyclodextrin‐based metal–organic frameworks (CD‐MOF) encapsulating dexamethasone (DXMS) and paeonol (Pae), while NaH particles are mounted on the basal part of each microneedle. By intranasal administration, the microneedles are propelled into the nasal mucosa by NaH‐generated hydrogen and then swell to form a hydrogel for sustainedly releasing drugs. The DXMS/Pae combination is demonstrated to be superior to more than the twofold dose of DXMS alone for improving allergic rhinitis in rats. It involves reducing mast cell degranulation and modulating Treg/Th17 cell homeostasis, whereas inhibiting Th1 to Th2 differentiation is associated with regulating the GATA3/T‐bet pathway, as well as repairing epithelial barrier function by increasing MUC1 and downregulating periostin. In addition, this delivery system modulates the lipid metabolism of the nasal mucosa. Notably, the newly designed device significantly enhances the drug's therapeutic effect, and NaH‐generated hydrogen may have the potential adjunctive therapeutic effect. Collectively, such an emerging microneedle‐mediated nasal drug delivery creates a new form for alleviating immune inflammation and contributes a promising solution to reduce clinical glucocorticoid abuse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneRhinitis, AllergicHydrogenAnimalsRatsMetal-Organic FrameworksNeedlesCyclodextrinsRats, Sprague-DawleyDrug Delivery SystemsNasal MucosaDelayed-Action PreparationsAdministration, IntranasalMaleAcetophenones

Stichwörter der Autor:innen

composite hydrogelsdissolving microneedlesglucocorticoidsmetal–organic frameworkssustained release

Substanzen

DexamethasoneHydrogenMetal-Organic FrameworksCyclodextrinsDelayed-Action PreparationsAcetophenones

Autor:innen und Institutionen

  • School of pharmacy, Shanghai University of Traditional Chinese Medicine, No.1200 Cailun Road, Pudong New Area, Shanghai, 201203, China.

ORCID-Profile: Yongtai Zhang

Förderung

  • National Natural Science Foundation of China
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning

Zitieren

APA

Ruan, H., Long, M., Li, J., Zhang, D., Feng, N., & Zhang, Y. (2024). Sustained‐Release Hydrogen‐Powered Bilateral Microneedles Integrating CD‐MOFs for In Situ Treating Allergic Rhinitis. Advanced Healthcare Materials, 13(22). https://doi.org/10.1002/adhm.202400637

Vancouver

Ruan H, Long M, Li J, Zhang D, Feng N, Zhang Y. Sustained‐Release Hydrogen‐Powered Bilateral Microneedles Integrating CD‐MOFs for In Situ Treating Allergic Rhinitis. Advanced Healthcare Materials. 2024;13(22). doi:10.1002/adhm.202400637

BibTeX
@article{Ruan2024,
  author = {Ruan, Hang and Long, Meng and Li, Jiaqi and Zhang, Di and Feng, Nianping and Zhang, Yongtai},
  title = {Sustained‐Release Hydrogen‐Powered Bilateral Microneedles Integrating CD‐MOFs for In Situ Treating Allergic Rhinitis},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {22},
  doi = {10.1002/adhm.202400637}
}
Kostenlos starten →